Neurological abnormalities in caveolin-1 knock out mice

被引:77
作者
Trushina, Eugenia
Du Charme, Jordan
Parisi, Joseph
McMurray, Cynthia T.
机构
[1] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA
[2] Mayo Clin, Mol Neurosci Program, Rochester, MN USA
[3] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
关键词
caveolin; knock out mouse model; neurological phenotype; brain histology;
D O I
10.1016/j.bbr.2006.04.024
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Caveolin-1 is the defining structural protein in caveolar vesicles, which regulate signal transduction and cholesterol trafficking in cells. In the brain, cav-1 is highly expressed in neurons and glia, but its function in those cell types is unclear. Mice deficient in cav-1 (CavKO) have been developed to test functional roles for cav-1 in various tissues. However, neurological phenotypes associated with loss of cav-1 in mice have not been evaluated. Here, we report the results of motor and behavioral testing of CavKO mice. We find that mice deficient in cav-1 have reduced brain weight and display a number of motor and behavioral abnormalities. CavKO mice develop neurological phenotypes including clasping, abnormal spinning, muscle weakness, reduced activity, and gait abnormalities. These data suggest that cav-1 is involved in maintaining cortico-stiiato-pallido-thalamo-pontine pathways associated with motor control. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:24 / 32
页数:9
相关论文
共 29 条
[1]   Membrane-associated estrogen receptor and caveolin-1 are present in central nervous system myelin and oligodendrocyte plasma membranes [J].
Arvanitis, DN ;
Wang, HM ;
Bagshaw, RD ;
Callahan, JW ;
Boggs, JM .
JOURNAL OF NEUROSCIENCE RESEARCH, 2004, 75 (05) :603-613
[2]   Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies [J].
Braff, DL ;
Geyer, MA ;
Swerdlow, NR .
PSYCHOPHARMACOLOGY, 2001, 156 (2-3) :234-258
[3]   A novel SNAP25-caveolin complex correlates with the onset of persistent synaptic potentiation [J].
Braun, JEA ;
Madison, DV .
JOURNAL OF NEUROSCIENCE, 2000, 20 (16) :5997-6006
[4]   Glutamate regulates caveolin expression in rat hippocampal neurons [J].
Bu, J ;
Bruckner, SR ;
Sengoku, T ;
Geddes, JW ;
Estus, S .
JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 72 (02) :185-190
[5]  
Cameron PL, 1997, J NEUROSCI, V17, P9520
[6]  
Carter RJ, 1999, J NEUROSCI, V19, P3248
[7]   Role of caveolae and caveolins in health and disease [J].
Cohen, AW ;
Hnasko, R ;
Schubert, W ;
Lisanti, MP .
PHYSIOLOGICAL REVIEWS, 2004, 84 (04) :1341-1379
[8]   Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts [J].
Cohen, AW ;
Park, DS ;
Woodman, SE ;
Williams, TM ;
Chandra, M ;
Shirani, J ;
De Souza, AP ;
Kitsis, RN ;
Russell, RG ;
Weiss, LM ;
Tang, BY ;
Jelicks, LA ;
Factor, SM ;
Shtutin, V ;
Tanowitz, HB ;
Lisanti, MP .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 284 (02) :C457-C474
[9]   Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice [J].
Drab, M ;
Verkade, P ;
Elger, M ;
Kasper, M ;
Lohn, M ;
Lauterbach, B ;
Menne, J ;
Lindschau, C ;
Mende, F ;
Luft, FC ;
Schedl, A ;
Haller, H ;
Kurzchalia, TV .
SCIENCE, 2001, 293 (5539) :2449-2452
[10]   A simple method to measure stride length as an index of nigrostriatal dysfunction in mice [J].
Fernagut, PO ;
Diguet, E ;
Labattu, B ;
Tison, F .
JOURNAL OF NEUROSCIENCE METHODS, 2002, 113 (02) :123-130